Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Bases de dados
Tipo de estudo
País/Região como assunto
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Transplantation ; 101(3): e68-e74, 2017 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-28222055

RESUMO

BACKGROUND: Vascularized composite allografts, particularly hand and forearm, have limited ischemic tolerance after procurement. In bilateral hand transplantations, this demands a 2 team approach and expedited transfer of the allograft, limiting the recovery to a small geographic area. Ex situ perfusion may be an alternative allograft preservation method to extend allograft survival time. This is a short report of 5 human limbs maintained for 24 hours with ex situ perfusion. METHODS: Upper limbs were procured from brain-dead organ donors. Following recovery, the brachial artery was cannulated and flushed with 10 000 U of heparin. The limb was then attached to a custom-made, near-normothermic (30-33°C) ex situ perfusion system composed of a pump, reservoir, and oxygenator. Perfusate was plasma-based with a hemoglobin concentration of 4 to 6 g/dL. RESULTS: Average warm ischemia time was 76 minutes. Perfusion was maintained at an average systolic pressure of 93 ± 2 mm Hg, flow 310 ± 20 mL/min, and vascular resistance 153 ± 16 mm Hg/L per minute. Average oxygen consumption was 1.1 ± 0.2 mL/kg per minute. Neuromuscular electrical stimulation continually displayed contraction until the end of perfusion, and histology showed no myocyte injury. CONCLUSIONS: Human limb allografts appeared viable after 24 hours of near-normothermic ex situ perfusion. Although these results are early and need validation with transplantation, this technology has promise for extending allograft storage times.


Assuntos
Aloenxertos Compostos/irrigação sanguínea , Aloenxertos Compostos/transplante , Preservação de Órgãos/métodos , Perfusão/métodos , Extremidade Superior/irrigação sanguínea , Extremidade Superior/cirurgia , Alotransplante de Tecidos Compostos Vascularizados/métodos , Adulto , Idoso , Biomarcadores/sangue , Morte Encefálica , Aloenxertos Compostos/inervação , Estimulação Elétrica , Desenho de Equipamento , Feminino , Hemodinâmica , Humanos , Masculino , Pessoa de Meia-Idade , Contração Muscular , Preservação de Órgãos/efeitos adversos , Preservação de Órgãos/instrumentação , Consumo de Oxigênio , Perfusão/efeitos adversos , Perfusão/instrumentação , Traumatismo por Reperfusão/etiologia , Traumatismo por Reperfusão/prevenção & controle , Fatores de Tempo , Doadores de Tecidos , Sobrevivência de Tecidos , Extremidade Superior/inervação , Alotransplante de Tecidos Compostos Vascularizados/efeitos adversos , Isquemia Quente
3.
Am J Transplant ; 5(4 Pt 2): 958-66, 2005 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15760421

RESUMO

Previous measures of OPO performance based on population counts have been deemed inadequate, and the need for new methods has been widely accepted. This article explains recent developments in OPO performance evaluation methodology, including those developed by the SRTR. As a replacement for the previously established measure of OPO performance--donors per million population--using eligible deaths as a national metric has yielded promising results for understanding variations in donation rates among the donation service areas assigned to each OPO. A major improvement uses "notifiable deaths" as a denominator describing a standardized maximal pool of potential donors. Notifiable deaths are defined as in-hospital deaths among ages 70 years and under, excluding certain diagnosis codes related to infections, cancers, etc. A most proximal denominator for determining donation rates is "eligible deaths," which includes only those deaths meeting the criteria for organ donation upon initial assessment. Neither measure is based on the population of a geographic unit, but on restricted upper limits of deaths that could be potential donors in any one locale (e.g., hospital or OPO). The inherent strengths and weaknesses of metrics such as donors per eligible deaths, donors per notifiable deaths, and number of organs per donor are discussed in detail.


Assuntos
Doadores de Tecidos/provisão & distribuição , Obtenção de Tecidos e Órgãos/estatística & dados numéricos , Transplante/estatística & dados numéricos , Humanos , Obtenção de Tecidos e Órgãos/organização & administração
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA